메뉴 건너뛰기
JAMA
Volumn 311, Issue 4, 2014, Pages 363-365
Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer?
Author keywords

[No Author keywords available]
Indexed keywords

EID: 84892691965     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.284665     Document Type: Editorial
Times cited : (10)
References (13)
  • 2
    • 78649352788 scopus 로고    scopus 로고
    • Epidemiology of pancreatic cancer: An update
    • Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an update. Dig Dis. 2010;28(4-5):645-656.
    • (2010) Dig Dis , vol.28 , Issue.4-5 , pp. 645-656
    • Maisonneuve, P.1    Lowenfels, A.B.2
  • 3
    • 84863708472 scopus 로고    scopus 로고
    • Accessibility verified December 26, 2013
    • American Cancer Society. Cancer facts and figures 2013. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/ document/acspc-036845.pdf. Accessibility verified December 26, 2013.
    • (2013) Cancer Facts and Figures
  • 4
    • 84885462618 scopus 로고    scopus 로고
    • Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: The CONKO-001 randomized trial
    • Oettle H, Neuhaus P, Hochhaus A, et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA. 2013;310(14):1473-1481.
    • (2013) JAMA , vol.310 , Issue.14 , pp. 1473-1481
    • Oettle, H.1    Neuhaus, P.2    Hochhaus, A.3
  • 5
    • 79955921754 scopus 로고    scopus 로고
    • FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
    • Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup
    • Conroy T, Desseigne F, Ychou M, et al Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817-1825.
    • (2011) N Engl J Med , vol.364 , Issue.19 , pp. 1817-1825
    • Conroy, T.1    Desseigne, F.2    Ychou, M.3
  • 6
    • 84886741654 scopus 로고    scopus 로고
    • Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
    • Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369(18):1691- 1703.
    • (2013) N Engl J Med , vol.369 , Issue.18 , pp. 1691-1703
    • Von Hoff, D.D.1    Ervin, T.2    Arena, F.P.3
  • 7
    • 84877746197 scopus 로고    scopus 로고
    • The clinical utility of CA 19-9 in pancreatic adenocarcinoma: Diagnostic and prognostic updates
    • Poruk KE, Gay DZ, Brown K, et al. The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr Mol Med. 2013;13(3):340-351.
    • (2013) Curr Mol Med , vol.13 , Issue.3 , pp. 340-351
    • Poruk, K.E.1    Gay, D.Z.2    Brown, K.3
  • 8
    • 84863115480 scopus 로고    scopus 로고
    • MicroRNA alterations of pancreatic intraepithelial neoplasias
    • Yu J, Li A, Hong SM, Hruban RH, Goggins M. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res. 2012;18(4):981-992.
    • (2012) Clin Cancer Res , vol.18 , Issue.4 , pp. 981-992
    • Yu, J.1    Li, A.2    Hong, S.M.3    Hruban, R.H.4    Goggins, M.5
  • 9
    • 84887350112 scopus 로고    scopus 로고
    • Genetic and molecular alterations in pancreatic cancer: Implications for personalized medicine
    • Fang Y, Yao Q, Chen Z, et al. Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine. Med Sci Monit. 2013;19:916-926.
    • (2013) Med Sci Monit , vol.19 , pp. 916-926
    • Fang, Y.1    Yao, Q.2    Chen, Z.3
  • 10
    • 84861578195 scopus 로고    scopus 로고
    • Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer
    • Liu J, Gao J, Du Y, et al. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer. 2012;131(3):683-691.
    • (2012) Int J Cancer , vol.131 , Issue.3 , pp. 683-691
    • Liu, J.1    Gao, J.2    Du, Y.3
  • 11
    • 84888352890 scopus 로고    scopus 로고
    • TargetingmicroRNAs in pancreatic cancer: Microplayers in the big game
    • Khan S, Ansarullah, Kumar D, Jaggi M, Chauhan SC. TargetingmicroRNAs in pancreatic cancer: microplayers in the big game. Cancer Res. 2013;73(22):6541-6547.
    • (2013) Cancer Res , vol.73 , Issue.22 , pp. 6541-6547
    • Khan, S.1    Ansarullah2    Kumar, D.3    Jaggi, M.4    Chauhan, S.C.5
  • 12
    • 84892689249 scopus 로고    scopus 로고
    • MicroRNA biomarkers in whole blood for detection of pancreatic cancer
    • doi:10.1001/jama.2013.284664
    • Schultz NA, Dehlendorff C, Jensen BV, et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA. doi:10.1001/jama.2013.284664.
    • JAMA
    • Schultz, N.A.1    Dehlendorff, C.2    Jensen, B.V.3
  • 13
    • 84867810635 scopus 로고    scopus 로고
    • MicroRNA in aging: From discovery to biology
    • Jung HJ, Suh Y. MicroRNA in aging: from discovery to biology. Curr Genomics. 2012;13(7):548-557.
    • (2012) Curr Genomics , vol.13 , Issue.7 , pp. 548-557
    • Jung, H.J.1    Suh, Y.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.